Raymond James Starts Maze Therapeutics (MAZE) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: MAZE) | Delayed: 30.37 -1.11 (3.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.48 | 52 Week High | $ | |||
| Open | $31.70 | 52 Week Low | $ | |||
| Day High | $31.70 | P/E | N/A | |||
| Day Low | $29.75 | EPS | $ | |||
| Volume | 331,183 | |||||
